抄録
Two new conjugates of 1-β-arabinofuranosylcytosine (ara-C) and lipids were tested for therapeutic activity in myelomonocytic WEHI-3B leukemia in mice. Both conjugates were superior to equimolar mixtures of their respective parent compounds and to ara-C alone. IP treatment was found effective after either IP or IV transplantation of the leukemia. The thioether-linked lipid conjugate ara-CDP-D,L-PTBA showed considerably higher efficacy than the ester-linked lipid conjugate ara-CDP-L-dipalmitin. The optimal therapeutic regimen of ara-CDP-D,L-PTBA consisted of 60 mg/kg given IP qd 1-5 after transplantation of the WEHI-3B leukemia.
本文言語 | English |
---|---|
ページ(範囲) | 364-367 |
ページ数 | 4 |
ジャーナル | Experimental Hematology |
巻 | 17 |
号 | 4 |
出版ステータス | Published - 1989 |
外部発表 | はい |
ASJC Scopus subject areas
- 分子生物学
- 血液学
- 遺伝学
- 細胞生物学
- 癌研究